• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺病变的细胞学评分及与组织病理学结果的比较。

Cytological Scoring of Breast Lesions and Comparison with Histopathological Findings.

作者信息

Abraham Betty, Sarojini T R

机构信息

Department of Cytology and Radiology, Pushpagiri Institute of Medical Sciences, Tiruvalla, Kerala, India.

出版信息

J Cytol. 2018 Oct-Dec;35(4):217-222. doi: 10.4103/JOC.JOC_84_17.

DOI:10.4103/JOC.JOC_84_17
PMID:30498293
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6210810/
Abstract

CONTEXT

Cytological assessment using various morphological parameters helps segregate breast lesions in fine-needle aspiration cytology (FNAC) into different categories. The prognosis and the line of management of each category differ accordingly.

AIMS

This study aims at assessing the validity of Modified Masood's Scoring Index (MMSI) by the evaluation of cytomorphological features of various breast lesions compared with histopathological findings.

SETTINGS AND DESIGN

This is a cross-sectional study done in 65 female patients with palpable or nonpalpable breast lesions, undergoing FNAC and biopsy over a period of 18 months from December 1, 2012, to May 31, 2014.

MATERIALS AND METHODS

MMSI categorizes breast lesions, based on six cytological parameters into different categories such as nonproliferative breast disease (NPBD), proliferative breast disease (PBD) without atypia, PBD with atypia, and malignancy. The findings are compared with gold standard histopathological diagnosis.

STATISTICAL ANALYSIS USED

Percentage of agreement, Kappa statistics, and Chi-square test.

RESULTS

Of the total 65 cases, all cases in MMSI category I and IV showed good histopathological correlation. The agreement between MMSI and histopathology was 93.8% which is more when compared with 72.3% agreement between cytology without scoring and histopathology. MMSI has increased the diagnostic accuracy of FNAC to 93.8% from 80%.

CONCLUSION

The scoring system is easily reproducible, simple, and reliable. MMSI proved good histopathological correlation in category I and IV. This scoring technique has clearly demarcated those cases requiring surgical management. It is applicable for palpable and nonpalpable cases.

摘要

背景

在细针穿刺细胞学检查(FNAC)中,利用各种形态学参数进行细胞学评估有助于将乳腺病变分为不同类别。相应地,每类病变的预后和处理方法也有所不同。

目的

本研究旨在通过评估各种乳腺病变的细胞形态学特征,并与组织病理学结果进行比较,来评估改良马苏德评分指数(MMSI)的有效性。

设置与设计

这是一项横断面研究,对65例有可触及或不可触及乳腺病变的女性患者进行了研究,这些患者在2012年12月1日至2014年5月31日的18个月期间接受了FNAC和活检。

材料与方法

MMSI根据六个细胞学参数将乳腺病变分为不同类别,如非增殖性乳腺疾病(NPBD)、无异型增生的增殖性乳腺疾病(PBD)、有异型增生的PBD和恶性肿瘤。将结果与金标准组织病理学诊断进行比较。

所用统计分析方法

一致性百分比、卡方统计和卡方检验。

结果

在总共65例病例中,MMSI I类和IV类中的所有病例均显示出良好的组织病理学相关性。MMSI与组织病理学之间的一致性为93.8%,与未评分细胞学和组织病理学之间72.3%的一致性相比更高。MMSI已将FNAC的诊断准确性从80%提高到93.8%。

结论

该评分系统易于重复、简单且可靠。MMSI在I类和IV类中证明了良好的组织病理学相关性。这种评分技术清楚地划分了那些需要手术处理的病例。它适用于可触及和不可触及的病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b5/6210810/33e50ec895d1/JCytol-35-217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b5/6210810/33e50ec895d1/JCytol-35-217-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/20b5/6210810/33e50ec895d1/JCytol-35-217-g004.jpg

相似文献

1
Cytological Scoring of Breast Lesions and Comparison with Histopathological Findings.乳腺病变的细胞学评分及与组织病理学结果的比较。
J Cytol. 2018 Oct-Dec;35(4):217-222. doi: 10.4103/JOC.JOC_84_17.
2
Masood's and Modified Masood's Scoring Index: An Evaluation of Fine Needle Aspiration Cytology of Breast Lesions with Histopathological Correlation.马苏德评分指数与改良马苏德评分指数:一项乳腺病变细针穿刺细胞学检查与组织病理学相关性的评估。
Acta Cytol. 2019;63(3):233-239. doi: 10.1159/000496139. Epub 2019 Feb 13.
3
Evaluation of Masood's and Modified Masood's Scoring Systems in the Cytological Diagnosis of Palpable Breast Lump Aspirates.马苏德评分系统和改良马苏德评分系统在可触及乳腺肿块抽吸物细胞学诊断中的评估
J Clin Diagn Res. 2017 Apr;11(4):EC06-EC10. doi: 10.7860/JCDR/2017/22817.9558. Epub 2017 Apr 1.
4
Comparison of the modified Masood's scoring index versus international academy of cytology Yokohama system in the categorization of breast fine needle aspirates.改良的 Masood 评分指数与国际细胞学会横滨系统在乳腺细针抽吸物分类中的比较。
Cytopathology. 2024 Nov;35(6):706-714. doi: 10.1111/cyt.13432. Epub 2024 Aug 7.
5
Diagnostic Accuracy of the International Academy of Cytology Yokohama System versus the Modified Masood's Scoring Index in Categorization and Diagnosis of Palpable Breast Lesions.国际细胞学会横滨系统与改良的 Masood 评分指数在触诊乳腺病变的分类和诊断中的诊断准确性比较。
Acta Cytol. 2023;67(3):280-288. doi: 10.1159/000527832. Epub 2022 Dec 14.
6
Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature.乳腺病变细胞学诊断及处理中评分系统的评估并文献复习
Indian J Cancer. 2011 Apr-Jun;48(2):240-5. doi: 10.4103/0019-509X.82891.
7
Feasibility of Masood's cytological index for screening breast lesions in low resource setting.Masood 细胞学指数在资源匮乏环境下用于筛查乳腺病变的可行性。
Breast J. 2019 May;25(3):434-438. doi: 10.1111/tbj.13239. Epub 2019 Apr 10.
8
Value of scoring system in classification of proliferative breast disease on fine needle aspiration cytology.评分系统在乳腺增生性疾病细针穿刺细胞学分类中的价值
Indian J Pathol Microbiol. 2006 Jul;49(3):334-40.
9
IAC standardized reporting of breast fine-needle aspiration cytology, Yokohama 2016: A critical appraisal over a 2 year period.IAC乳腺细针穿刺细胞学标准化报告,横滨2016:两年期批判性评估
Breast Dis. 2019;38(3-4):109-115. doi: 10.3233/BD-190393.
10
Efficacy of Modified Masood Scoring System (MMSS) in Cytological Diagnosis of Breast Lesions.改良马苏德评分系统(MMSS)在乳腺病变细胞学诊断中的效能
Cureus. 2022 Feb 16;14(2):e22296. doi: 10.7759/cureus.22296. eCollection 2022 Feb.

本文引用的文献

1
Expansion of Masood's cytologic index for breast carcinoma and its validity.马斯ood乳腺癌细胞学指数的扩展及其有效性。
J Cytol. 2013 Oct;30(4):233-6. doi: 10.4103/0970-9371.126647.
2
Comparison of ultrasonography and fine needle aspiration cytology in the diagnosis of malignant breast lesions.超声检查与细针穿刺细胞学检查在乳腺恶性病变诊断中的比较。
J Clin Diagn Res. 2013 Dec;7(12):2847-50. doi: 10.7860/JCDR/2013/6493.3887. Epub 2013 Nov 12.
3
Utility of fine needle aspiration cytology in the evaluation of breast lesions.细针穿刺细胞学检查在乳腺病变评估中的应用
J Clin Diagn Res. 2013 Dec;7(12):2777-9. doi: 10.7860/JCDR/2013/6507.3756. Epub 2013 Dec 15.
4
Evaluation of scoring system in cytological diagnosis and management of breast lesion with review of literature.乳腺病变细胞学诊断及处理中评分系统的评估并文献复习
Indian J Cancer. 2011 Apr-Jun;48(2):240-5. doi: 10.4103/0019-509X.82891.
5
Breast fine-needle aspiration samples reported as "proliferative breast lesion": clinical utility of the subcategory "proliferative breast lesion with atypia".报告为“增殖性乳腺病变”的乳腺细针穿刺样本:“非典型增殖性乳腺病变”亚类的临床应用
Cancer. 2009 Apr 25;117(2):137-47. doi: 10.1002/cncy.20003.
6
[Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].[乳腺针吸细胞学检查:对其在诊断和管理中作用的当前观点]
Acta Med Croatica. 2008 Oct;62(4):391-401.
7
Role of fine needle aspiration cytology in diagnosis of breast lumps.细针穿刺细胞学检查在乳腺肿块诊断中的作用
Kathmandu Univ Med J (KUMJ). 2007 Apr-Jun;5(2):215-7.
8
Cytomorphology of fibrocystic change, high-risk proliferative breast disease, and premalignant breast lesions.纤维囊性变、高危增殖性乳腺疾病及癌前乳腺病变的细胞形态学
Clin Lab Med. 2005 Dec;25(4):713-31, vi. doi: 10.1016/j.cll.2005.08.005.
9
The significance of the diagnosis of atypia in breast fine-needle aspiration.乳腺细针穿刺活检中不典型性诊断的意义
Diagn Cytopathol. 2004 Nov;31(5):285-8. doi: 10.1002/dc.20123.
10
Fine needle aspiration cytology in the UK breast screening programme: a national audit of results.英国乳腺筛查项目中的细针穿刺细胞学检查:结果的全国性审核
Breast. 1999 Oct;8(5):261-6. doi: 10.1054/brst.1999.0068.